日本新薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2016/03/22 | 4,055 | 4,175 | 4,040 | 4,065 | +85 | +2.1% | 565,800 |
2016/03/18 | 3,900 | 3,995 | 3,885 | 3,980 | +50 | +1.3% | 440,700 |
2016/03/17 | 3,955 | 4,000 | 3,895 | 3,930 | -45 | -1.1% | 405,000 |
2016/03/16 | 4,030 | 4,055 | 3,950 | 3,975 | -95 | -2.3% | 288,100 |
2016/03/15 | 4,065 | 4,100 | 4,030 | 4,070 | -20 | -0.5% | 259,000 |
2016/03/14 | 4,130 | 4,145 | 4,045 | 4,090 | ±0 | ±0% | 260,400 |
2016/03/11 | 4,070 | 4,150 | 4,060 | 4,090 | +20 | +0.5% | 417,200 |
2016/03/10 | 4,025 | 4,120 | 4,005 | 4,070 | +90 | +2.3% | 231,600 |
2016/03/09 | 3,965 | 4,015 | 3,925 | 3,980 | +15 | +0.4% | 290,000 |
2016/03/08 | 4,100 | 4,100 | 3,840 | 3,965 | -165 | -4% | 433,500 |
2016/03/07 | 4,150 | 4,180 | 4,065 | 4,130 | -45 | -1.1% | 267,500 |
2016/03/04 | 4,250 | 4,260 | 4,145 | 4,175 | -75 | -1.8% | 251,700 |
2016/03/03 | 4,200 | 4,290 | 4,190 | 4,250 | +40 | +1% | 287,600 |
2016/03/02 | 4,040 | 4,245 | 3,985 | 4,210 | +240 | +6% | 563,900 |
2016/03/01 | 3,880 | 4,000 | 3,850 | 3,970 | +100 | +2.6% | 308,500 |
2016/02/29 | 3,910 | 3,990 | 3,860 | 3,870 | +35 | +0.9% | 218,600 |
2016/02/26 | 3,870 | 3,965 | 3,820 | 3,835 | +20 | +0.5% | 224,300 |
2016/02/25 | 3,795 | 3,840 | 3,770 | 3,815 | +10 | +0.3% | 329,000 |
2016/02/24 | 3,785 | 3,880 | 3,775 | 3,805 | -25 | -0.7% | 219,100 |
2016/02/23 | 3,870 | 3,935 | 3,775 | 3,830 | -50 | -1.3% | 209,500 |
2016/02/22 | 3,800 | 3,925 | 3,800 | 3,880 | +40 | +1% | 289,600 |
2016/02/19 | 3,885 | 3,945 | 3,805 | 3,840 | -70 | -1.8% | 221,800 |
2016/02/18 | 3,885 | 3,950 | 3,810 | 3,910 | +150 | +4% | 195,600 |
2016/02/17 | 3,875 | 3,910 | 3,715 | 3,760 | -125 | -3.2% | 285,900 |
2016/02/16 | 3,900 | 3,950 | 3,860 | 3,885 | -60 | -1.5% | 318,400 |
2016/02/15 | 4,035 | 4,045 | 3,875 | 3,945 | +90 | +2.3% | 502,000 |
2016/02/12 | 3,810 | 3,940 | 3,675 | 3,855 | -80 | -2% | 581,300 |
2016/02/10 | 4,195 | 4,215 | 3,900 | 3,935 | -240 | -5.7% | 495,100 |
2016/02/09 | 4,080 | 4,275 | 4,005 | 4,175 | -45 | -1.1% | 770,400 |
2016/02/08 | 4,115 | 4,265 | 4,100 | 4,220 | +45 | +1.1% | 292,400 |
2016/02/05 | 4,210 | 4,305 | 4,150 | 4,175 | -150 | -3.5% | 270,300 |
2016/02/04 | 4,485 | 4,520 | 4,310 | 4,325 | -200 | -4.4% | 354,700 |
2016/02/03 | 4,425 | 4,550 | 4,370 | 4,525 | +85 | +1.9% | 529,000 |
2016/02/02 | 4,275 | 4,470 | 4,275 | 4,440 | +120 | +2.8% | 207,700 |
2016/02/01 | 4,205 | 4,345 | 4,195 | 4,320 | +150 | +3.6% | 257,200 |
2016/01/29 | 4,185 | 4,190 | 4,030 | 4,170 | -25 | -0.6% | 337,100 |
2016/01/28 | 4,110 | 4,235 | 4,090 | 4,195 | +10 | +0.2% | 205,800 |
2016/01/27 | 4,175 | 4,235 | 4,115 | 4,185 | +65 | +1.6% | 219,400 |
2016/01/26 | 4,110 | 4,200 | 4,090 | 4,120 | -5 | -0.1% | 205,700 |
2016/01/25 | 4,120 | 4,170 | 4,000 | 4,125 | +100 | +2.5% | 335,500 |
2016/01/22 | 3,960 | 4,035 | 3,885 | 4,025 | +135 | +3.5% | 557,600 |
2016/01/21 | 4,005 | 4,050 | 3,890 | 3,890 | -175 | -4.3% | 606,700 |
2016/01/20 | 4,235 | 4,245 | 4,055 | 4,065 | -50 | -1.2% | 333,700 |
2016/01/19 | 4,065 | 4,150 | 4,050 | 4,115 | +5 | +0.1% | 330,800 |
2016/01/18 | 4,055 | 4,145 | 4,040 | 4,110 | -75 | -1.8% | 402,300 |
2016/01/15 | 4,220 | 4,255 | 4,130 | 4,185 | +30 | +0.7% | 457,900 |
2016/01/14 | 4,210 | 4,240 | 4,025 | 4,155 | -45 | -1.1% | 580,300 |
2016/01/13 | 4,220 | 4,285 | 4,135 | 4,200 | +30 | +0.7% | 498,100 |
2016/01/12 | 4,250 | 4,300 | 4,110 | 4,170 | -170 | -3.9% | 527,200 |
2016/01/08 | 4,300 | 4,420 | 4,210 | 4,340 | ±0 | ±0% | 488,600 |
2251~
2300
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
ペプチド | 168,300円 | +5.0% | +1.5% | 0.00% | 14.40倍 | 3.83倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム